Min Zhou

机构：Guangzhou Medical University Cancer Hospital, Guangzhou Medical University · ORCID：0009-0008-9266-7780

发表论文 13 篇 · 总被引 38 次 · h-index 3

代表论文

• Metal-polyphenol polymer modified polydopamine for chemo-photothermal therapy (2023 · Frontiers in Chemistry · 被引 13)
• Liposomal mitoxantrone monotherapy in patients with relapsed or refractory mature T‐cell and natural killer‐cell neoplasms: A phase 2, multicenter, open‐label, single‐arm trial (2025 · Cancer · 被引 11)
• A Novel Dual Covalent and Non-Covalent Next Generation Inhibitor of Bruton's Tyrosine Kinase LP-168 in Patients with Relapsed/Refractory B Cell Non-Hodgkin Lymphoma: Safety and Efficacy Results from a Phase 1 Study (2023 · Blood · 被引 6)
• Efficacy and safety of rocbrutinib, a highly selective 4th-generation BTK inhibitor, in Chinese patients with chronic lymphocytic leukemia/small lymphocytic lymphoma (CLL/SLL) (2025 · Blood · 被引 3)
• PSF-lncRNA interaction as a target for novel targeted anticancer therapies (2024 · Biomedicine & Pharmacotherapy · 被引 3)
• Safety and Efficacy of Rocbrutinib in Patients with Relapsed/Refractory Marginal Zone Lymphoma (2024 · Blood · 被引 2)